Modern literature data are presented on the choice of a drug for hormonal therapy in acute neurosensory hearing loss of various origins, the doses used for systemic therapy, the features and methods of intratympanic administration of glucocorticosteroids, and the evaluation of the effectiveness of treatment with this group of drugs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17116/otorino20228705170 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Regulation of the blood-brain barrier function by peripheral cues in health and disease.
Metab Brain Dis
December 2024
Institute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
The blood-brain barrier (BBB) is formed by microvascular endothelial cells which are ensembled with pericytes, astrocytes, microglia and neurons in the neurovascular unit (NVU) that is crucial for neuronal function. Given that the NVU and the BBB are highly dynamic and regulated structures, their integrity is continuously challenged by intrinsic and extrinsic factors. Herein, factors from peripheral organs such as gonadal and adrenal hormones may influence vascular function also in CNS endothelial cells in a sex- and age-dependent manner.
View Article and Find Full Text PDFBilateral asynchronous acute idiopathic maculopathy with disease recurrence.
Am J Ophthalmol Case Rep
December 2024
Casey Eye Institute at Oregon Health and Science University, 515 SW Campus Dr., Portland, OR, 97239, USA.
Purpose: Acute idiopathic maculopathy (AIM) is a posterior segment disorder that involves the neurosensory retina, retinal pigment epithelium, and choroidal circulation. When first described, the disease was classified as unilateral, but subsequent reports have found bilateral presentations. There is growing evidence to suggest the coxsackie virus as the etiology, however, other pro-inflammatory conditions have also been temporally linked to fundoscopic findings.
View Article and Find Full Text PDFProton Radiation Therapy: A Systematic Review of Treatment-Related Side Effects and Toxicities.
Int J Mol Sci
October 2024
New York Proton Center, New York, NY 10035, USA.
Article Synopsis
- - Cancer is the second leading cause of death globally, and about 50% of patients receive radiation therapy, predominantly photon radiation, despite advancements in proton radiation therapy (PBT) that aims to minimize damage to healthy tissue.
- - Proton therapy utilizes the Bragg peak property of protons to deliver targeted radiation with potentially lower toxicity compared to photon therapy, but patients may still experience proton-specific side effects.
- - Reported toxicities from proton therapy include issues related to the brain, lungs, heart, gastrointestinal system, and genitourinary system; while similar to those from photon therapy, they generally occur less frequently.
Meningitis and neurosensory hypoacousia due to Rickettsia sp. in Peru: case report.
Rev Peru Med Exp Salud Publica
October 2024
Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú.
We present the case of a young female health worker, resident in a high Andean region of Peru, with recent exposure to farm animals and arthropods, who developed acute febrile undifferentiated syndrome, severe thrombocytopenia and pulmonary and abdominal extravasation. Subsequently, the patient developed meningitis and early onset bilateral neurosensorial hypoacusis and showed reactive serology to acute infection by Rickettsia sp. Epidemiological and clinical considerations in the differential diagnosis for early management are discussed.
View Article and Find Full Text PDFA pilot cross-sectional investigation of symptom clusters and associations with patient-reported outcomes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition.
Qual Life Res
December 2024
National Centre for Neuroimmunology and Emerging Diseases, Griffith University, 1 Parklands Drive, Southport Gold Coast, Brisbane, QLD, 4222, Australia.
Article Synopsis
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post COVID-19 Condition (PCC) share similar debilitating symptoms, including fatigue and cognitive issues, impacting quality of life and functionality.
- The study involved Australian adults with ME/CFS and PCC, using self-reported questionnaires to assess symptoms and health outcomes, revealing significant differences in age and symptom associations between the two groups.
- Findings suggest that illness duration influences symptom severity, highlighting the need for clearer diagnostic criteria for PCC to better identify individuals at risk of developing chronic ME/CFS-like illnesses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!